Rigel Pharmaceuticals (RIGL) Cash from Financing Activities (2010 - 2026)
Rigel Pharmaceuticals' quarterly Cash from Financing Activities came in at -$10.9 million in Q1 2026, down 2355.99% year-on-year from $484000.0 in Q1 2025, and down 138.82% quarter-over-quarter from -$4.6 million in Q4 2025.
Rigel Pharmaceuticals has reported Cash from Financing Activities for 17 years, with the latest figure at -$10.9 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 2355.99% year-over-year to -$10.9 million; the trailing twelve-month figure through Mar 2026 stood at -$10.8 million (down 24.95% YoY), and the FY2025 full-year result was $601000.0, up 105.16% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$10.9 million, down from -$4.6 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $19.1 million in Q1 2023, with the low at -$10.9 million in Q1 2026.
- Average Cash from Financing Activities over 5 years is $174000.0, with a median of -$373000.0 recorded in 2023.
- Year-over-year, Cash from Financing Activities jumped 1911.31% in 2022 and slumped 2355.99% in 2026.
- Tracing RIGL's Cash from Financing Activities over 5 years: stood at -$2.1 million in 2022, then jumped by 123.19% to $486000.0 in 2023, then soared by 201.44% to $1.5 million in 2024, then plunged by 412.08% to -$4.6 million in 2025, then sank by 138.82% to -$10.9 million in 2026.
- The last three Cash from Financing Activities figures came in at -$10.9 million (Q1 2026), -$4.6 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | -10.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.92 Mn |
| Mar 31, 2026 | -10.92 Mn |
| Dec 31, 2025 | -4.57 Mn |
| Dec 31, 2025 | -4.57 Mn |
| Sep 30, 2025 | 4.27 Mn |
| Sep 30, 2025 | 4.27 Mn |
| Jun 30, 2025 | 418,000.00 |
| Jun 30, 2025 | 418,000.00 |
| Mar 31, 2025 | 484,000.00 |
| Mar 31, 2025 | 484,000.00 |
| Dec 31, 2024 | 1.47 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Sep 30, 2024 | -9.84 Mn |
| Sep 30, 2024 | -9.84 Mn |
| Jun 30, 2024 | -752,000.00 |
| Jun 30, 2024 | -752,000.00 |
| Mar 31, 2024 | -2.51 Mn |
| Mar 31, 2024 | -2.51 Mn |
| Dec 31, 2023 | 486,000.00 |
| Dec 31, 2023 | 486,000.00 |
| Sep 30, 2023 | -869,000.00 |
| Sep 30, 2023 | -869,000.00 |
| Jun 30, 2023 | -373,000.00 |
| Jun 30, 2023 | -373,000.00 |
| Mar 31, 2023 | 19.12 Mn |
| Mar 31, 2023 | 19.12 Mn |
| Dec 31, 2022 | -2.10 Mn |
| Dec 31, 2022 | -2.10 Mn |
| Sep 30, 2022 | 5.51 Mn |
| Sep 30, 2022 | 5.51 Mn |
| Jun 30, 2022 | -5.66 Mn |
| Jun 30, 2022 | -5.66 Mn |
| Mar 31, 2022 | 8.80 Mn |
| Mar 31, 2022 | 8.80 Mn |
| Dec 31, 2021 | 1.09 Mn |
| Dec 31, 2021 | 1.09 Mn |
| Sep 30, 2021 | 274,000.00 |
| Sep 30, 2021 | 274,000.00 |
| Jun 30, 2021 | 59.22 Mn |
| Jun 30, 2021 | 59.22 Mn |
| Mar 31, 2021 | 2.10 Mn |
| Mar 31, 2021 | 2.10 Mn |
| Dec 31, 2020 | 667,000.00 |
| Dec 31, 2020 | 667,000.00 |
| Sep 30, 2020 | 52,000.00 |
| Sep 30, 2020 | 52,000.00 |
| Jun 30, 2020 | 10.52 Mn |
| Jun 30, 2020 | 10.52 Mn |
| Mar 31, 2020 | 1.34 Mn |
| Mar 31, 2020 | 1.34 Mn |
| Dec 31, 2019 | 694,000.00 |
| Dec 31, 2019 | 694,000.00 |
| Sep 30, 2019 | 9.80 Mn |
| Sep 30, 2019 | 9.80 Mn |
| Jun 30, 2019 | 856,000.00 |
| Jun 30, 2019 | 856,000.00 |
| Mar 31, 2019 | 16,000.00 |
| Mar 31, 2019 | 16,000.00 |
| Dec 31, 2018 | 1.10 Mn |
| Dec 31, 2018 | 1.10 Mn |
| Sep 30, 2018 | 635,000.00 |
| Sep 30, 2018 | 635,000.00 |
| Jun 30, 2018 | 68.15 Mn |
| Jun 30, 2018 | 68.15 Mn |
| Mar 31, 2018 | 2.01 Mn |
| Mar 31, 2018 | 2.01 Mn |
| Dec 31, 2017 | 67.37 Mn |
| Dec 31, 2017 | 67.37 Mn |
| Sep 30, 2017 | 3.34 Mn |
| Sep 30, 2017 | 3.34 Mn |
| Jun 30, 2017 | 3.56 Mn |
| Jun 30, 2017 | 3.56 Mn |
| Mar 31, 2017 | 43.42 Mn |
| Mar 31, 2017 | 43.42 Mn |
| Dec 31, 2016 | 2.04 Mn |
| Dec 31, 2016 | 2.04 Mn |
| Sep 30, 2016 | 13.18 Mn |
| Sep 30, 2016 | 13.18 Mn |
| Jun 30, 2016 | 9.96 Mn |
| Jun 30, 2016 | 9.96 Mn |
| Mar 31, 2016 | 4,000.00 |
| Mar 31, 2016 | 4,000.00 |
| Dec 31, 2015 | 5.93 Mn |
| Dec 31, 2015 | 5.93 Mn |
| Sep 30, 2015 | 98,000.00 |
| Sep 30, 2015 | 98,000.00 |
| Jun 30, 2015 | 1.01 Mn |
| Jun 30, 2015 | 1.01 Mn |
| Mar 31, 2015 | 17,000.00 |
| Mar 31, 2015 | 17,000.00 |
| Dec 31, 2014 | 480,000.00 |
| Dec 31, 2014 | 480,000.00 |
| Sep 30, 2014 | 5,000.00 |
| Sep 30, 2014 | 5,000.00 |
| Jun 30, 2014 | 661,000.00 |
| Jun 30, 2014 | 661,000.00 |
| Mar 31, 2014 | 24,000.00 |
| Mar 31, 2014 | 24,000.00 |
| Dec 31, 2013 | 229,000.00 |
| Dec 31, 2013 | 229,000.00 |
| Dec 31, 2012 | 136.53 Mn |
| Dec 31, 2012 | 136.53 Mn |
| Sep 30, 2012 | 1.20 Mn |
| Sep 30, 2012 | 1.20 Mn |
| Jun 30, 2012 | 885,000.00 |
| Jun 30, 2012 | 885,000.00 |
| Mar 31, 2012 | 488,000.00 |
| Mar 31, 2012 | 488,000.00 |
| Dec 31, 2011 | 769,000.00 |
| Dec 31, 2011 | 769,000.00 |
| Sep 30, 2011 | 21,000.00 |
| Sep 30, 2011 | 21,000.00 |
| Jun 30, 2011 | 141.39 Mn |
| Jun 30, 2011 | 141.39 Mn |
| Mar 31, 2011 | -199,000.00 |
| Mar 31, 2011 | -199,000.00 |
| Dec 31, 2010 | 506,000.00 |
| Dec 31, 2010 | 506,000.00 |
| Sep 30, 2010 | -34,000.00 |
| Sep 30, 2010 | -34,000.00 |